Pharmaceutical APIs
Idelalisib
Active Pharmaceutical Ingredient — Neurology
Idelalisib is a PI3K delta inhibitor used in treatment of certain B-cell malignancies including chronic lymphocytic leukemia.
- CAS Number
- 870281-82-6
- Therapeutic Area
- Neurology
- Drug Class
- Anticancer Agents
- Molecular Formula
- C22H18FN7O
- Molecular Weight
- 415.4
- PubChem CID
- 11625818
RFQ / Inquiry
Request Idelalisib
Send a structured RFQ to APINEXA's coordination team — confidential, supplier-matched, audit-grade. Typical response in 24 business hours.